반응식
CC1(C)C(C)(C)OB([C:9]2[CH2:14][CH2:13][CH:12]([C:15]([O:17][CH2:18][CH3:19])=[O:16])[CH2:11][CH:10]=2)O1.Cl[C:22]1[C:31]([Cl:32])=[CH:30][C:29]2[C:24](=[CH:25][CH:26]=[C:27]([O:33][CH3:34])[CH:28]=2)[N:23]=1>>[Cl:32][C:31]1[C:22]([C:9]2[CH2:14][CH2:13][CH:12]([C:15]([O:17][CH2:18][CH3:19])=[O:16])[CH2:11][CH:10]=2)=[N:23][C:24]2[C:29]([CH:30]=1)=[CH:28][C:27]([O:33][CH3:34])=[CH:26][CH:25]=2참가 물질
3
실험 절차
Followed Scheme 2, Step 1 (see Ex. 8, Step 1) starting from ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate and 2,3-dichloro-6-methoxyquinoline (Intermediate 4).
출처 및 근거
- ORD 기록
- ord-93f9628c5811462c9da13b2575985330
- 출처 데이터셋
- uspto-grants-2016_04
- 특허 번호
- US09315462B2
연결된 노트
불러오는 중…